|Articles|December 1, 1995

November/December 1995
Volume 1
Issue 3

Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Author(s)Ira J. Goodman, MD

Download PDF: Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Articles in this issue

about 30 years ago

Article

Life-Effectiveness Analysis: A Technique for Trading Clinical Life-Years for Societal Life-Years

about 30 years ago

Article

Proton Pump Inhibitors Versus H2-Receptor Antagonists for the Treatment of Erosive Gastroesophageal Reflux Disease: A Cost-Comparative Study

about 30 years ago

Article

Antihypertensive Therapy: Factors Affecting Medication Compliance and Blood Pressure Control

about 30 years ago

Article

Appropriate Use of Abdominal Ultrasonography in Two Hospitals

about 30 years ago

Article

Long-Term Management of Gastroesophageal Reflux Disease

about 30 years ago

Article

Life-Effectiveness Analysis -- More Shadow Than Light?

about 30 years ago

Article

The Role of the AHCPR in Clinical Guidelines Development

about 30 years ago

Article

Modeling Member Satisfaction in the Management of Pediatric Nocturnal Enuresis

about 30 years ago

Article

The Opportunities for Educational Interventions in the Psychosocial and Behavioral Barriers to Asthma Management

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Cost-Benefit Analysis of Epilepsy Treatment by the Neurologist

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era